Search
Quick Filters
Clinical Trials Data
Showing 3475 of 543136 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 07/14/21
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 11/14/22
End: 01/30/23
Due: 01/30/24
Phase: N/A
Priority: Normal
Start: 10/11/23
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 04/30/22
End: 04/01/28
Due: 04/01/29
Phase: N/A
Priority: Normal
Start: 01/28/20
End: 04/18/23
Due: 04/18/24
Phase: N/A
Priority: Normal
Start: 06/30/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/27/22
End: 06/03/22
Due: 06/03/23
Phase: N/A
Priority: Normal
Start: 07/31/02
End: 05/31/05
Due: 05/31/06
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 12/30/23
Due: 12/30/24
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 06/12/24
Due: 06/12/25
Phase: N/A
Priority: Normal
Start: 11/01/19
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 04/13/17
Due: 04/13/18
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 01/01/27
Due: 01/01/28
Phase: N/A
Priority: Normal
Start: 02/15/16
End: 06/15/16
Due: 06/15/17
Phase: N/A
Priority: Normal
Start: 03/15/16
End: 12/01/22
Due: 12/01/23
Phase: N/A
Priority: Normal
Start: 04/20/22
End: 05/28/23
Due: 05/28/24
Phase: N/A
Priority: Normal
Start: 02/28/93
End: 02/28/02
Due: 02/28/03
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 05/01/22
Due: 05/01/23
Phase: N/A
Priority: Normal
Start: 07/09/19
End: 05/15/22
Due: 05/15/23
Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 01/23/23
End: 06/25/24
Due: 06/25/25
Phase: N/A
Priority: Normal
Start: 09/19/12
End: 01/15/18
Due: 01/15/19
Phase: N/A
Priority: Normal
Start: 08/15/22
End: 04/15/23
Due: 04/15/24